TAVNEOS Support
Amgen
This page describes financial assistance programs for the TAVNEOS medication itself, including a copay program for commercially insured patients and a patient assistance program for uninsured or underinsured individuals. It does not provide any information about a travel assistance grant, nor does it list any coverage for travel-related expenses.
- Covers
- financial assistance
- Enrollment cycle
- rolling
Eligibility
The program is available to adults with severe active ANCA-associated vasculitis who are commercially insured and not covered by government-funded healthcare programs. Uninsured patients or those unable to afford medication may also apply for support through Amgen’s nonprofit patient assistance program.
Apply
Application goes directly to Amgen. RxCopays does not receive compensation.
Go to application →Status source
Patients will need to complete a Patient Assistance Program application
Rare-disease support beyond financial help
This grant covers a rare condition. For specialists, clinical trials, and patient communities, our sister site UniteRare.org has in-depth pages: